Liang Ma
- Aging top 5%
-
- Spine and Intervertebral Disc Pathology 4
- Biomedical Engineering top 5%
- Bone Tissue Engineering Materials 15
- Nanoplatforms for cancer theranostics 12
- Graphene and Nanomaterials Applications 4
- Biomaterials top 5%
- Pharmacology top 5%
-
- Alzheimer's disease research and treatments 10
-
- Parkinson's Disease Mechanisms and Treatments 4
-
- Extracellular vesicles in disease 4
-
- MXene and MAX Phase Materials 4
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Liang Ma
57 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Aging 56
- Pathology and Forensic Medicine 406
- Biomedical Engineering 950
- Biomaterials 248
- Pharmacology 268
Countries citing papers authored by Liang Ma
This map shows the geographic impact of Liang Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang Ma more than expected).
Fields of papers citing papers by Liang Ma
This network shows the impact of papers produced by Liang Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang Ma. The network helps show where Liang Ma may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Liang Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 12 | |
| 4 | 2023 | 38 | |
| 5 | 2023 | 53 | |
| 6 | 2023 | 16 | |
| 7 | Cytosolic escape of mitochondrial DNA triggers cGAS-STING-NLRP3 axis-dependent nucleus pulposus cell pyroptosisbreakdown → | 2022 | 226 |
| 8 | 2022 | 108 | |
| 9 | 2022 | 103 | |
| 10 | 2021 | 96 | |
| 11 | 2021 | 16 | |
| 12 | 2021 | 107 | |
| 13 | 2021 | 52 | |
| 14 | 2021 | 69 | |
| 15 | 2021 | 35 | |
| 16 | 2021 | 107 | |
| 17 | 2020 | 58 | |
| 18 | 2020 | 71 | |
| 19 | 2019 | 78 | |
| 20 | 2019 | 27 |
About Liang Ma
Liang Ma is a scholar working on Aging, Clinical Biochemistry and Orthopedics and Sports Medicine, having authored 58 papers that have together received 2.8k indexed citations. Recurring topics across this work include Bone Tissue Engineering Materials (15 papers), Nanoplatforms for cancer theranostics (12 papers), Alzheimer's disease research and treatments (10 papers), Parkinson's Disease Mechanisms and Treatments (4 papers), Graphene and Nanomaterials Applications (4 papers), Spine and Intervertebral Disc Pathology (4 papers), Extracellular vesicles in disease (4 papers) and MXene and MAX Phase Materials (4 papers). The work is most often cited by research in Aging (56 citations), Pathology and Forensic Medicine (406 citations) and Biomedical Engineering (950 citations). Liang Ma has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Yang Cao, Xiaobo Feng, Gaocai Li, Yu Song, Zhiwei Liao, Kun Huang, Rongjin Luo, Bingjin Wang, Jie Lei and Xiangmei Liu. Their work appears in journals such as Advanced Materials, Nature Communications and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.